The University of Chicago Header Logo

Connection

Stephen Kent to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Stephen Kent has written about Drug Evaluation, Preclinical.
Stephen Kent
Connection Strength
0.046
Drug Evaluation, Preclinical
  1. A Non-immunogenic Bivalent d-Protein Potently Inhibits Retinal Vascularization and Tumor Growth. ACS Chem Biol. 2021 03 19; 16(3):548-556.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.